# Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)

> **NCT05604859** · PHASE4 · UNKNOWN · sponsor: **Qin Ning** · enrollment: 350 (estimated)

## Conditions studied

- Severe Fever With Thrombocytopenia Syndrome

## Interventions

- **DRUG:** Methylprednisolone
- **DRUG:** intravenous immunoglobulin
- **DRUG:** Tocilizumab
- **DRUG:** Low molecular weight heparin
- **OTHER:** conventional treatment

## Key facts

- **NCT ID:** NCT05604859
- **Lead sponsor:** Qin Ning
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-19
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2023-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05604859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05604859, "Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05604859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*